Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.

Subjects: Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/blood ; Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/complications ; Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2024 Aug 08; Vol. 391 (6), pp. 493-503. Date of Electronic Publication: 2024 Jun 02.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.

Subjects: Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/blood ; Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/complications ; Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/Adrenal Hyperplasia, Congenital*/drug therapy Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

  • Source: The New England journal of medicine [N Engl J Med] 2024 Aug 08; Vol. 391 (6), pp. 504-514. Date of Electronic Publication: 2024 Jun 01.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Adjuvant Alpelisib Therapy for Congenital Hyperinsulinism.

Subjects: Congenital Hyperinsulinism*/Congenital Hyperinsulinism*/Congenital Hyperinsulinism*/drug therapy ; Thiazoles*/Thiazoles*/Thiazoles*/therapeutic use ; Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/Class I Phosphatidylinositol 3-Kinases*/therapeutic use

  • Source: The New England journal of medicine [N Engl J Med] 2024 Jan 25; Vol. 390 (4), pp. 379-380.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.

Subjects: Transcatheter Aortic Valve Replacement*/Transcatheter Aortic Valve Replacement*/Transcatheter Aortic Valve Replacement*/adverse effects; 4-Hydroxycoumarins/4-Hydroxycoumarins/4-Hydroxycoumarins/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2021 Dec 02; Vol. 385 (23), pp. 2150-2160. Date of Electronic Publication: 2021 Aug 28.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.

Subjects: Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Embolism/Embolism/Embolism/*prevention & control ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*administration & dosage

  • Source: The New England journal of medicine [N Engl J Med] 2020 Oct 29; Vol. 383 (18), pp. 1735-1745. Date of Electronic Publication: 2020 Aug 30.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Critical Illness/Critical Illness/Critical Illness/*psychology ; Delirium/Delirium/Delirium/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2018 Dec 27; Vol. 379 (26), pp. 2506-2516. Date of Electronic Publication: 2018 Oct 22.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Edoxaban for Cancer-Associated Venous Thromboembolism.

Subjects: Thiazoles* ; Venous Thromboembolism*; Humans

  • Source: The New England journal of medicine [N Engl J Med] 2018 Jul 05; Vol. 379 (1), pp. 93.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Edoxaban for Cancer-Associated Venous Thromboembolism.

  • Authors : Nasser NJ; Montefiore Medical Center, Bronx, New York

Subjects: Thiazoles* ; Venous Thromboembolism*; Humans

  • Source: The New England journal of medicine [N Engl J Med] 2018 Jul 05; Vol. 379 (1), pp. 94-5.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Edoxaban for Cancer-Associated Venous Thromboembolism.

  • Authors : Raskob GE; University of Oklahoma Health Sciences Center, Oklahoma City, OK ; Büller HR

Subjects: Thiazoles* ; Venous Thromboembolism*; Administration, Oral

  • Source: The New England journal of medicine [N Engl J Med] 2018 Jul 05; Vol. 379 (1), pp. 95-96.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  119 results for ""THIAZOLES""